This is the program for the 2010 Joint Statistical Meetings in Vancouver, British Columbia.

Abstract Details

Activity Number: 256
Type: Contributed
Date/Time: Monday, August 2, 2010 : 2:00 PM to 3:50 PM
Sponsor: Biopharmaceutical Section
Abstract - #307465
Title: Characterizing the Mutation Pathway for Integrase Inhibitor
Author(s): Jing Zhao*+
Companies: Merck Research Laboratories
Address: , , ,
Keywords: Bayesian model selection ; Mutation Pathway ; Markov Chain Monte Carlo (MCMC)

A wide variety of mutations in the viral genome of Human Immunodeficiency Virus Type-1 (HIV-1) are associated with reduced susceptibility to Antiretroviral Therapies (ARTs). Identifying pathways in which viral populations progress genotypically in the presence (or absence) of particular therapies, especially the new class Integrase Inhibitor may provide insight into the mechanism of resistance and help make more informed treatment decisions.

Our aim is to characterize statistically the dependency among viral genetic loci measured over time. We propose an exploratory Bayesian model selection procedure to identify Markov models that best describe this mutation process. This procedure is built on a 3-stage hierarchical mixture model for the Markov model uncertainty. This exploratory approach to characterizing the viral genetic pathways can provide interesting biological/clinical insight.

The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.

Back to the full JSM 2010 program

2010 JSM Online Program Home

For information, contact or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.